aromasil has been researched along with Adenocarcinoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Brown-Glaberman, UA; Budd, GT; Burkard, ME; Connolly, RM; Faller, BA; Kaufman, PA; Lee, MJ; Levine, EG; Miller, KD; Onitilo, AA; Piekarz, RL; Royce, ME; Smith, KL; Sparano, JA; Thomas, A; Trepel, JB; Winn, JS; Wolff, AC; Zhao, F | 1 |
| Blok, EJ; Derks, MGM; Dirix, LY; Hasenburg, A; Kranenbarg, EM; Kroep, JR; Liefers, GJ; Markopoulos, C; Nortier, JWR; Paridaens, R; Putter, H; Rea, D; Seynaeve, C; Smeets, JBE; van de Velde, CJH | 1 |
| Briceño, CA; Jackson, K; Sulewski, ME | 1 |
| Dafni, U; Gogas, H; Koukouras, D; Markopoulos, C; Polychronis, A; Tzorakoleftherakis, E; Xepapadakis, G; Zobolas, V | 1 |
| Glück, S | 1 |
| Bertolini, E; Letho-Gyselinck, H; Prati, C; Wendling, D | 1 |
| Amano, S; Enomoto, K; Sakurai, K | 1 |
| Asmar, L; Bartlett, JM; Hadji, P; Hasenburg, A; Hille, ET; Hozumi, Y; Jones, SE; Kieback, DG; Markopoulos, C; Nortier, JW; Paridaens, R; Putter, H; Rea, D; Seynaeve, C; Smeets, J; van de Velde, CJ; Vannetzel, JM | 1 |
| Coombes, RC; Kilburn, LS | 1 |
1 review(s) available for aromasil and Adenocarcinoma
| Article | Year |
|---|---|
Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Celecoxib; Estrogens; Female; Humans; Letrozole; Middle Aged; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Pyrazoles; Randomized Controlled Trials as Topic; Recurrence; Salvage Therapy; Sulfonamides; Tamoxifen; Triazoles | 2010 |
4 trial(s) available for aromasil and Adenocarcinoma
| Article | Year |
|---|---|
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzamides; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Double-Blind Method; Drug Administration Schedule; Female; Histone Deacetylase Inhibitors; Humans; Male; Middle Aged; Progression-Free Survival; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; South Africa; Time Factors; United States | 2021 |
Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.
Topics: Adenocarcinoma; Aged; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mastectomy; Middle Aged; Postmenopause; Tamoxifen; Time Factors; Treatment Outcome | 2017 |
Lipid changes in breast cancer patients on exemestane treatment: final results of the TEAM Greek substudy.
Topics: Adenocarcinoma; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cross-Over Studies; Female; Greece; Humans; Lipid Metabolism; Lipids; Postmenopause; Tamoxifen | 2009 |
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Early Diagnosis; Female; Humans; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 2011 |
4 other study(ies) available for aromasil and Adenocarcinoma
| Article | Year |
|---|---|
Progressive Restrictive Strabismus in an Adult Woman.
Topics: Adenocarcinoma; Androstadienes; Antineoplastic Agents; Brachytherapy; Breast Neoplasms; Female; Humans; Middle Aged; Oculomotor Muscles; Orbital Neoplasms; Strabismus | 2017 |
Rheumatoid arthritis and aromatase inhibitors.
Topics: Adenocarcinoma; Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Arthritis, Rheumatoid; Breast Neoplasms; Carcinoma, Ductal; Combined Modality Therapy; Female; Humans; Letrozole; Middle Aged; Nitriles; Triazoles | 2011 |
[A successful case of the super elderly breast cancer patient treated with exemestane].
Topics: Adenocarcinoma; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Female; Humans | 2010 |
Time to TEAM: exemestane, or tamoxifen then exemestane?
Topics: Adenocarcinoma; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Female; Humans; Postmenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Translational Research, Biomedical | 2011 |